Annual Long Term Debt
$1.41 B
+$6.91 M+0.49%
December 31, 2024
Summary
- As of March 12, 2025, IONS annual long term debt is $1.41 billion, with the most recent change of +$6.91 million (+0.49%) on December 31, 2024.
- During the last 3 years, IONS annual long term debt has risen by +$159.77 million (+12.81%).
- IONS annual long term debt is now at all-time high.
Performance
IONS Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$1.41 B
+$5.10 M+0.36%
December 31, 2024
Summary
- As of March 12, 2025, IONS quarterly long term debt is $1.41 billion, with the most recent change of +$5.10 million (+0.36%) on December 31, 2024.
- Over the past year, IONS quarterly long term debt has increased by +$6.91 million (+0.49%).
- IONS quarterly long term debt is now -5.57% below its all-time high of $1.49 billion, reached on June 30, 2023.
Performance
IONS Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
IONS Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.5% | +0.5% |
| 3 y3 years | +12.8% | -3.1% |
| 5 y5 years | +82.8% | -3.1% |
IONS Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +12.8% | -5.6% | +15.1% |
| 5 y | 5-year | at high | +134.5% | -5.6% | +134.5% |
| alltime | all time | at high | >+9999.0% | -5.6% | >+9999.0% |
Ionis Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.41 B(+0.5%) | $1.41 B(+0.4%) |
| Sep 2024 | - | $1.40 B(+0.2%) |
| Jun 2024 | - | $1.40 B(-0.1%) |
| Mar 2024 | - | $1.40 B(-0.1%) |
| Dec 2023 | $1.40 B(+2.8%) | $1.40 B(-3.6%) |
| Sep 2023 | - | $1.45 B(-2.5%) |
| Jun 2023 | - | $1.49 B(+9.5%) |
| Mar 2023 | - | $1.36 B(-0.0%) |
| Dec 2022 | $1.36 B(+9.1%) | $1.36 B(+11.2%) |
| Sep 2022 | - | $1.22 B(+0.1%) |
| Jun 2022 | - | $1.22 B(+0.1%) |
| Mar 2022 | - | $1.22 B(-2.0%) |
| Dec 2021 | $1.25 B(+107.9%) | $1.25 B(+2.3%) |
| Sep 2021 | - | $1.22 B(+0.1%) |
| Jun 2021 | - | $1.22 B(+43.7%) |
| Mar 2021 | - | $847.97 M(+41.3%) |
| Dec 2020 | $600.12 M(-22.1%) | $600.12 M(-24.9%) |
| Sep 2020 | - | $798.93 M(+1.2%) |
| Jun 2020 | - | $789.18 M(+1.2%) |
| Mar 2020 | - | $779.59 M(+1.3%) |
| Dec 2019 | $769.96 M(+22.6%) | $769.96 M(+17.3%) |
| Sep 2019 | - | $656.25 M(+1.5%) |
| Jun 2019 | - | $646.67 M(+1.5%) |
| Mar 2019 | - | $637.27 M(+1.5%) |
| Dec 2018 | $628.06 M(+5.9%) | $628.06 M(+1.5%) |
| Sep 2018 | - | $619.01 M(+1.5%) |
| Jun 2018 | - | $610.13 M(+1.4%) |
| Mar 2018 | - | $601.42 M(+1.4%) |
| Dec 2017 | $592.88 M(+3.5%) | $592.88 M(+1.4%) |
| Sep 2017 | - | $584.49 M(+3.0%) |
| Jun 2017 | - | $567.56 M(-2.3%) |
| Mar 2017 | - | $580.81 M(+1.4%) |
| Dec 2016 | $572.87 M(+24.1%) | $572.87 M(+19.3%) |
| Sep 2016 | - | $480.33 M(+1.3%) |
| Jun 2016 | - | $473.96 M(+1.3%) |
| Mar 2016 | - | $467.71 M(+1.3%) |
| Dec 2015 | $461.59 M(+3.2%) | $461.59 M(-0.5%) |
| Sep 2015 | - | $463.98 M(+1.2%) |
| Jun 2015 | - | $458.29 M(+1.2%) |
| Mar 2015 | - | $452.70 M(+1.2%) |
| Dec 2014 | $447.23 M(+101.8%) | $447.23 M(+97.0%) |
| Sep 2014 | - | $227.05 M(+0.8%) |
| Jun 2014 | - | $225.20 M(+0.8%) |
| Mar 2014 | - | $223.40 M(+0.8%) |
| Dec 2013 | $221.62 M(+3.3%) | $221.62 M(+0.8%) |
| Sep 2013 | - | $219.80 M(+0.8%) |
| Jun 2013 | - | $218.01 M(+0.8%) |
| Mar 2013 | - | $216.26 M(+0.8%) |
| Dec 2012 | $214.54 M(+1.5%) | $214.54 M(-3.0%) |
| Sep 2012 | - | $221.28 M(-2.0%) |
| Jun 2012 | - | $225.74 M(+3.9%) |
| Mar 2012 | - | $217.36 M(+2.9%) |
| Dec 2011 | $211.32 M(+42.1%) | $211.32 M(-0.7%) |
| Sep 2011 | - | $212.86 M(+5.8%) |
| Jun 2011 | - | $201.26 M(+34.1%) |
| Mar 2011 | - | $150.05 M(+0.9%) |
| Dec 2010 | $148.76 M(+8.9%) | $148.76 M(+2.4%) |
| Sep 2010 | - | $145.33 M(+0.5%) |
| Jun 2010 | - | $144.67 M(+2.2%) |
| Mar 2010 | - | $141.61 M(+3.7%) |
| Dec 2009 | $136.58 M(-20.8%) | $136.58 M(+0.6%) |
| Sep 2009 | - | $135.80 M(+2.8%) |
| Jun 2009 | - | $132.11 M(+0.8%) |
| Mar 2009 | - | $131.08 M(-24.0%) |
| Dec 2008 | $172.44 M(+5.9%) | $172.44 M(+2.7%) |
| Sep 2008 | - | $167.98 M(+0.0%) |
| Jun 2008 | - | $167.91 M(+3.1%) |
| Mar 2008 | - | $162.89 M(+0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | $162.86 M(+22.6%) | $162.86 M(-1.1%) |
| Sep 2007 | - | $164.72 M(-1.1%) |
| Jun 2007 | - | $166.55 M(-1.1%) |
| Mar 2007 | - | $168.39 M(+26.8%) |
| Dec 2006 | $132.82 M(-5.1%) | $132.82 M(-1.4%) |
| Sep 2006 | - | $134.74 M(-1.1%) |
| Jun 2006 | - | $136.17 M(-1.3%) |
| Mar 2006 | - | $137.94 M(-1.4%) |
| Dec 2005 | $139.91 M(-40.9%) | $139.91 M(-1.4%) |
| Sep 2005 | - | $141.84 M(-42.0%) |
| Jun 2005 | - | $244.43 M(+0.4%) |
| Mar 2005 | - | $243.36 M(+2.9%) |
| Dec 2004 | $236.61 M(+10.9%) | $236.61 M(+3.2%) |
| Sep 2004 | - | $229.37 M(+2.4%) |
| Jun 2004 | - | $224.03 M(+2.0%) |
| Mar 2004 | - | $219.56 M(+2.9%) |
| Dec 2003 | $213.40 M(+3.0%) | $213.40 M(+12.7%) |
| Sep 2003 | - | $189.39 M(-0.4%) |
| Jun 2003 | - | $190.22 M(-4.9%) |
| Mar 2003 | - | $199.95 M(-3.5%) |
| Dec 2002 | $207.26 M(+64.9%) | $207.26 M(+15.9%) |
| Sep 2002 | - | $178.84 M(-6.7%) |
| Jun 2002 | - | $191.66 M(+43.1%) |
| Mar 2002 | - | $133.92 M(+6.5%) |
| Dec 2001 | $125.71 M(+22.9%) | $125.71 M(+1.7%) |
| Sep 2001 | - | $123.65 M(+6.9%) |
| Jun 2001 | - | $115.67 M(+10.7%) |
| Mar 2001 | - | $104.45 M(+2.2%) |
| Dec 2000 | $102.25 M(+17.1%) | $102.25 M(+6.1%) |
| Sep 2000 | - | $96.33 M(+1.9%) |
| Jun 2000 | - | $94.50 M(+3.5%) |
| Mar 2000 | - | $91.30 M(+4.6%) |
| Dec 1999 | $87.30 M(+12.4%) | $87.30 M(+1.7%) |
| Sep 1999 | - | $85.80 M(+4.3%) |
| Jun 1999 | - | $82.30 M(+4.3%) |
| Mar 1999 | - | $78.90 M(+1.5%) |
| Dec 1998 | $77.70 M(+37.5%) | $77.70 M(+5.1%) |
| Sep 1998 | - | $73.90 M(+2.8%) |
| Jun 1998 | - | $71.90 M(+26.8%) |
| Mar 1998 | - | $56.70 M(+0.4%) |
| Dec 1997 | $56.50 M(+183.9%) | $56.50 M(+65.7%) |
| Sep 1997 | - | $34.10 M(+1.8%) |
| Jun 1997 | - | $33.50 M(+69.2%) |
| Mar 1997 | - | $19.80 M(-0.5%) |
| Dec 1996 | $19.90 M(+323.4%) | $19.90 M(+298.0%) |
| Sep 1996 | - | $5.00 M(+2.0%) |
| Jun 1996 | - | $4.90 M(-7.5%) |
| Mar 1996 | - | $5.30 M(+12.8%) |
| Dec 1995 | $4.70 M(-49.5%) | $4.70 M(-41.3%) |
| Sep 1995 | - | $8.00 M(-4.8%) |
| Jun 1995 | - | $8.40 M(-5.6%) |
| Mar 1995 | - | $8.90 M(-4.3%) |
| Dec 1994 | $9.30 M(+5.7%) | $9.30 M(-4.1%) |
| Sep 1994 | - | $9.70 M(+21.3%) |
| Jun 1994 | - | $8.00 M(-4.8%) |
| Mar 1994 | - | $8.40 M(-4.5%) |
| Dec 1993 | $8.80 M(+31.3%) | $8.80 M(+7.3%) |
| Sep 1993 | - | $8.20 M(+15.5%) |
| Jun 1993 | - | $7.10 M(+7.6%) |
| Mar 1993 | - | $6.60 M(-1.5%) |
| Dec 1992 | $6.70 M(+34.0%) | $6.70 M(-1.5%) |
| Sep 1992 | - | $6.80 M(+1.5%) |
| Jun 1992 | - | $6.70 M(+19.6%) |
| Mar 1992 | - | $5.60 M(+12.0%) |
| Dec 1991 | $5.00 M(+455.6%) | $5.00 M(+61.3%) |
| Sep 1991 | - | $3.10 M(+6.9%) |
| Jun 1991 | - | $2.90 M(+190.0%) |
| Mar 1991 | - | $1.00 M(+11.1%) |
| Dec 1990 | $900.00 K | $900.00 K |
FAQ
- What is Ionis Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual long term debt year-on-year change?
- What is Ionis Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly long term debt year-on-year change?
What is Ionis Pharmaceuticals annual long term debt?
The current annual long term debt of IONS is $1.41 B
What is the all time high annual long term debt for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual long term debt is $1.41 B
What is Ionis Pharmaceuticals annual long term debt year-on-year change?
Over the past year, IONS annual long term debt has changed by +$6.91 M (+0.49%)
What is Ionis Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of IONS is $1.41 B
What is the all time high quarterly long term debt for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly long term debt is $1.49 B
What is Ionis Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, IONS quarterly long term debt has changed by +$6.91 M (+0.49%)